IL151308A0 - PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT - Google Patents

PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Info

Publication number
IL151308A0
IL151308A0 IL15130801A IL15130801A IL151308A0 IL 151308 A0 IL151308 A0 IL 151308A0 IL 15130801 A IL15130801 A IL 15130801A IL 15130801 A IL15130801 A IL 15130801A IL 151308 A0 IL151308 A0 IL 151308A0
Authority
IL
Israel
Prior art keywords
hcg
purification
pharmaceutical compositions
ion
compositions containing
Prior art date
Application number
IL15130801A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL151308A0 publication Critical patent/IL151308A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL15130801A 2000-02-22 2001-01-22 PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT IL151308A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (1)

Publication Number Publication Date
IL151308A0 true IL151308A0 (en) 2003-04-10

Family

ID=8167925

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15130801A IL151308A0 (en) 2000-02-22 2001-01-22 PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IL151308A IL151308A (en) 2000-02-22 2002-08-18 Cleansing of hCG and pharmaceutical preparations containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151308A IL151308A (en) 2000-02-22 2002-08-18 Cleansing of hCG and pharmaceutical preparations containing it

Country Status (32)

Country Link
US (2) US7297777B2 (ja)
EP (2) EP1752466A3 (ja)
JP (1) JP4588960B2 (ja)
KR (1) KR100806911B1 (ja)
CN (1) CN100482679C (ja)
AT (1) ATE406378T1 (ja)
AU (2) AU783320B2 (ja)
BG (1) BG65807B1 (ja)
BR (1) BRPI0108556B8 (ja)
CA (1) CA2399020A1 (ja)
CY (1) CY1108460T1 (ja)
CZ (1) CZ303144B6 (ja)
DE (1) DE60135541D1 (ja)
DK (1) DK1257564T3 (ja)
EA (1) EA006605B1 (ja)
EE (1) EE05644B1 (ja)
ES (1) ES2307585T3 (ja)
HK (1) HK1052016A1 (ja)
HR (1) HRP20020650B1 (ja)
HU (2) HU228935B1 (ja)
IL (2) IL151308A0 (ja)
ME (1) ME00296B (ja)
MX (1) MXPA02007871A (ja)
NO (1) NO328694B1 (ja)
PL (1) PL205149B1 (ja)
PT (1) PT1257564E (ja)
RS (1) RS50741B (ja)
SI (1) SI1257564T1 (ja)
SK (1) SK287146B6 (ja)
UA (2) UA86938C2 (ja)
WO (1) WO2001062773A1 (ja)
ZA (1) ZA200206109B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399020A1 (en) * 2000-02-22 2001-08-30 Applied Research Systems Ars Holding N.V. Process of purification of hcg and recombinant hcg purified by that method
CA2582083A1 (en) * 2004-10-04 2006-04-20 Novetide, Ltd. A counterion exchange process for peptides
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
EA200802426A1 (ru) * 2006-07-11 2009-04-28 Коваль, Антон Александрович Применение хорионического или лютеинизирующего гормона для профилактики или лечения возрастного гипогонадизма
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
EP2691119B1 (en) 2011-03-31 2018-08-01 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053864C (en) * 1989-02-21 2001-11-20 Irving Boime Modified forms of reproductive hormones
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
PT814841E (pt) 1995-03-21 2002-03-28 Applied Research Systems Formulacoes liquidas de hcg
AU706504B2 (en) * 1996-02-20 1999-06-17 Merck Serono Sa Hybrid proteins which form heterodimers
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
WO1998056806A1 (en) 1997-06-12 1998-12-17 The Regents Of The University Of California A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP
PT998486E (pt) * 1997-06-13 2007-08-21 Genentech Inc ''recuperação de proteínas por cromatografia seguida de filtração numa camada carregada''
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
CA2399020A1 (en) * 2000-02-22 2001-08-30 Applied Research Systems Ars Holding N.V. Process of purification of hcg and recombinant hcg purified by that method

Also Published As

Publication number Publication date
EE200200469A (et) 2004-04-15
PL357508A1 (en) 2004-07-26
EP1257564A1 (en) 2002-11-20
ATE406378T1 (de) 2008-09-15
UA78488C2 (en) 2007-04-10
HRP20020650B1 (en) 2011-02-28
HU228935B1 (en) 2013-06-28
CA2399020A1 (en) 2001-08-30
EA006605B1 (ru) 2006-02-24
MEP38908A (en) 2011-02-10
RS50741B (sr) 2010-08-31
US7297777B2 (en) 2007-11-20
CY1108460T1 (el) 2014-04-09
ES2307585T3 (es) 2008-12-01
EP1752466A2 (en) 2007-02-14
WO2001062773A1 (en) 2001-08-30
BR0108556A (pt) 2003-01-28
BG107000A (en) 2003-04-30
AU2680401A (en) 2001-09-03
IL151308A (en) 2009-11-18
KR100806911B1 (ko) 2008-02-22
HUP0204231A2 (hu) 2003-03-28
AU2006200059A1 (en) 2006-02-02
MXPA02007871A (es) 2003-02-10
JP4588960B2 (ja) 2010-12-01
NO20023985L (no) 2002-08-21
BRPI0108556B1 (pt) 2015-04-14
SK287146B6 (sk) 2010-01-07
YU60202A (sh) 2005-09-19
KR20030001359A (ko) 2003-01-06
CN1404485A (zh) 2003-03-19
CZ303144B6 (cs) 2012-05-02
HU1300063D0 (hu) 2003-03-28
EP1752466A3 (en) 2012-10-10
BG65807B1 (bg) 2009-12-31
BRPI0108556B8 (pt) 2021-05-25
NO20023985D0 (no) 2002-08-21
EP1257564B1 (en) 2008-08-27
HK1052016A1 (en) 2003-08-29
PL205149B1 (pl) 2010-03-31
UA86938C2 (uk) 2009-06-10
PT1257564E (pt) 2008-09-10
JP2003524015A (ja) 2003-08-12
ME00296B (me) 2011-05-10
DK1257564T3 (da) 2008-10-06
NO328694B1 (no) 2010-04-26
DE60135541D1 (de) 2008-10-09
ZA200206109B (en) 2003-07-31
US20070299001A1 (en) 2007-12-27
AU783320B2 (en) 2005-10-13
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
EA200200892A1 (ru) 2003-02-27
CZ20022855A3 (cs) 2002-11-13
HRP20020650A2 (en) 2004-12-31
CN100482679C (zh) 2009-04-29
EE05644B1 (et) 2013-04-15
HUP0204231A3 (en) 2005-09-28
SI1257564T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
IL151308A0 (en) PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IL151309A0 (en) Purification of lh and pharmaceutical compositions containing it
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
CY1107666T1 (el) Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης
IL98528A0 (en) Pharmaceutical compositions containing hybrid for killing bladder cancer cells